These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 34192638

  • 21. Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.
    Miernyk KM, Bulkow LR, Case SL, Zulz T, Bruce MG, Harker-Jones M, Hurlburt DA, Hennessy TW, Rudolph KM.
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):224-30. PubMed ID: 27498610
    [Abstract] [Full Text] [Related]

  • 22. Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
    Golden AR, Baxter MR, Davidson RJ, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Hoban DJ, Zhanel GG, Adam HJ, Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD.
    J Antimicrob Chemother; 2019 Aug 01; 74(Suppl 4):iv39-iv47. PubMed ID: 31505644
    [Abstract] [Full Text] [Related]

  • 23. Serotype distribution, antimicrobial resistance and prevalence of pilus islets in pneumococci following the use of conjugate vaccines.
    Kawaguchiya M, Urushibara N, Aung MS, Shinagawa M, Takahashi S, Kobayashi N.
    J Med Microbiol; 2017 May 01; 66(5):643-650. PubMed ID: 28516842
    [Abstract] [Full Text] [Related]

  • 24. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
    Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N, Mitsuyama J, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2014 Jul 01; 20(7):423-8. PubMed ID: 24802765
    [Abstract] [Full Text] [Related]

  • 25. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
    Diawara I, Barguigua A, Katfy K, Nayme K, Belabbes H, Timinouni M, Zerouali K, Elmdaghri N.
    Ann Clin Microbiol Antimicrob; 2017 Apr 04; 16(1):23. PubMed ID: 28376809
    [Abstract] [Full Text] [Related]

  • 26. Genetic diversity of pneumococcal surface protein A (PspA) in paediatric isolates of non-conjugate vaccine serotypes in Japan.
    Kawaguchiya M, Urushibara N, Aung MS, Morimoto S, Ito M, Kudo K, Kobayashi N.
    J Med Microbiol; 2018 Aug 04; 67(8):1130-1138. PubMed ID: 29927374
    [Abstract] [Full Text] [Related]

  • 27. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.
    Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.
    Antimicrob Agents Chemother; 2014 Nov 04; 58(11):6484-9. PubMed ID: 25136018
    [Abstract] [Full Text] [Related]

  • 28. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
    Lee JK, Yun KW, Choi EH, Kim SJ, Lee SY, Lee HJ.
    J Korean Med Sci; 2017 Sep 04; 32(9):1431-1439. PubMed ID: 28776337
    [Abstract] [Full Text] [Related]

  • 29. Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020.
    Golden AR, Adam HJ, Karlowsky JA, Baxter M, Schellenberg J, Martin I, Demczuk W, Minion J, Van Caeseele P, Kus JV, McGeer A, Lefebvre B, Smadi H, Haldane D, Yu Y, Mead K, Mulvey MR, Zhanel GG.
    J Antimicrob Chemother; 2023 May 03; 78(Suppl 1):i26-i36. PubMed ID: 37130587
    [Abstract] [Full Text] [Related]

  • 30. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ.
    Clin Microbiol Infect; 2009 Apr 03; 15 Suppl 3():4-6. PubMed ID: 19366362
    [Abstract] [Full Text] [Related]

  • 31. Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain.
    Sempere J, de Miguel S, González-Camacho F, Yuste J, Domenech M.
    Front Microbiol; 2020 Apr 03; 11():309. PubMed ID: 32174903
    [Abstract] [Full Text] [Related]

  • 32. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.
    Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL, Tan TQ, Hoffman JA, Bradley JS, Givner LB, Mason EO, Hultén KG.
    J Clin Microbiol; 2017 Mar 03; 55(3):724-734. PubMed ID: 27847379
    [Abstract] [Full Text] [Related]

  • 33. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
    Miller E, Andrews NJ, Waight PA, Slack MP, George RC.
    Lancet Infect Dis; 2011 Oct 03; 11(10):760-8. PubMed ID: 21621466
    [Abstract] [Full Text] [Related]

  • 34. Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.
    Demczuk WHB, Martin I, Desai S, Griffith A, Caron-Poulin L, Lefebvre B, McGeer A, Tyrrell GJ, Zhanel GG, Gubbay J, Hoang L, Levett PN, Van Caeseele P, Raafat Gad R, Haldane D, Zahariadis G, German G, Daley Bernier J, Strudwick L, Mulvey MR.
    Vaccine; 2018 Jul 25; 36(31):4701-4707. PubMed ID: 29937245
    [Abstract] [Full Text] [Related]

  • 35. Streptococcus pneumoniae Serotypes 9 and 14 Circulating in Brazil over a 23-Year Period Prior to Introduction of the 10-Valent Pneumococcal Conjugate Vaccine: Role of International Clones in the Evolution of Antimicrobial Resistance and Description of a Novel Genotype.
    Pinto TC, Kegele FC, Dias CA, Barros RR, Peralta JM, Merquior VL, Carvalho MD, Chochua S, Hawkins P, McGee L, Teixeira LM.
    Antimicrob Agents Chemother; 2016 Nov 25; 60(11):6664-6672. PubMed ID: 27572394
    [Abstract] [Full Text] [Related]

  • 36. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 37. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K.
    Hum Vaccin Immunother; 2014 Dec 31; 10(7):1866-73. PubMed ID: 25424794
    [Abstract] [Full Text] [Related]

  • 38. Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C.
    Neves FPG, Cardoso NT, Snyder RE, Marlow MA, Cardoso CAA, Teixeira LM, Riley LW.
    Vaccine; 2017 May 15; 35(21):2794-2800. PubMed ID: 28431817
    [Abstract] [Full Text] [Related]

  • 39. Comparison of PCV-10 and PCV-13 vaccine coverage for invasive pneumococcal isolates obtained across Canadian geographic regions, SAVE 2011 to 2017.
    Hink RK, Adam HJ, Golden AR, Baxter M, Martin I, Nichol KA, Demczuk W, Mulvey MR, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2021 Mar 15; 99(3):115282. PubMed ID: 33341491
    [Abstract] [Full Text] [Related]

  • 40. Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine.
    Maraki S, Samonis G, Galanakis E.
    Eur J Clin Microbiol Infect Dis; 2010 Nov 15; 29(11):1449-51. PubMed ID: 20617352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.